1. Home
  2. MTD vs NTRA Comparison

MTD vs NTRA Comparison

Compare MTD & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mettler-Toledo International Inc.

MTD

Mettler-Toledo International Inc.

HOLD

Current Price

$1,231.53

Market Cap

27.8B

Sector

Industrials

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$193.43

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTD
NTRA
Founded
1991
2003
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.8B
28.0B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
MTD
NTRA
Price
$1,231.53
$193.43
Analyst Decision
Buy
Strong Buy
Analyst Count
12
15
Target Price
$1,444.17
$259.07
AVG Volume (30 Days)
126.6K
1.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
3.88
0.65
EPS
42.05
N/A
Revenue
$4,026,399,000.00
$210,939,000.00
Revenue This Year
$6.07
$18.08
Revenue Next Year
$4.75
$19.65
P/E Ratio
$31.31
N/A
Revenue Growth
3.98
N/A
52 Week Low
$1,029.23
$131.81
52 Week High
$1,525.17
$256.36

Technical Indicators

Market Signals
Indicator
MTD
NTRA
Relative Strength Index (RSI) 39.57 44.66
Support Level $1,161.00 $186.89
Resistance Level $1,290.85 $204.34
Average True Range (ATR) 34.25 9.78
MACD -3.00 -0.13
Stochastic Oscillator 2.79 27.50

Price Performance

Historical Comparison
MTD
NTRA

About MTD Mettler-Toledo International Inc.

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: